INFLAMASE FORTE Rx
Generic Name and Formulations:
Prednisolone sodium phosphate 1%; oph soln; contains benzalkonium chloride.
Indications for INFLAMASE FORTE:
Initially 1–2 drops every hour during day and every 2 hours at night; after response, reduce to 1 drop every 4 hours; then 1 drop 3–4 times daily as needed.
Ocular fungal, mycobacterial, viral (except herpes zoster), or untreated bacterial infections.
Not for use after uncomplicated removal of foreign body. Corneal or scleral thinning. Glaucoma. Monitor IOP and for secondary infections. Avoid abrupt cessation in prolonged use. Pregnancy (Cat.C). Nursing mothers.
Prolonged use: increased IOP, cataracts, corneal perforations, optic nerve damage, delayed wound healing; may mask or worsen infections.
Soln—5mL, 10mL, 15mL
Sign Up for Free e-newsletters
- Choice of Breast Reconstruction After Mastectomy Affects Satisfaction, Quality of Life
- Bariatric Surgery Reduced Risk of Some Cancers in Obese Patients
- Carfilzomib Benefits May Outweigh Cardiovascular Risk in Multiple Myeloma
- The Caregivers' Cancer Journey
- Genetic Link Between Depression and Breast Cancer Remains Unclear
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
- Fertility Preservation in Hodgkin's Lymphoma Patients That Undergo Targeted Molecular Therapies: An Important Step Forward From the Chemotherapy Era
- Survey of ACEP Councilors Reveals NP, PA Staffing Models, Practice Patterns Vary
- Breath Analysis May Be an Effective Diagnostic for Pancreatic Cancer
- Genetic Susceptibility to Pancreatic Cancer Linked to 6 Specific Gene Mutations
- Dinner Hour and Sleep Habits Affect Risk of Breast, Prostate Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|